Esquire Financial Holdings (ESQ) director reports 753-share restricted stock grant

Rhea-AI Filing Summary

Esquire Financial Holdings, Inc. disclosed that one of its directors received a grant of 753 shares of restricted common stock on December 10, 2025. The shares were awarded at $0 per share and are scheduled to vest 100% on December 10, 2026.

After this grant, the director beneficially owns 142,679 shares of common stock directly, which include multiple restricted stock awards that vest in three equal annual installments beginning on dates between December 19, 2023 and December 15, 2027. In addition, the director indirectly owns 2,500 shares through an insurance trust I and 2,500 shares through an insurance trust II.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mitzman Robert

(Last) (First) (Middle)

100 JERICHO QUADRANGLE

SUITE 100

(Street)

JERICHO NY 11753

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Esquire Financial Holdings, Inc. [ ESQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/10/2025		A		753(1)	A	$0	142,679(2)(3)(4)(5)(6)(7)	D
Common Stock								2,500	I	By insurance trust I
Common Stock								2,500	I	By insurance trust II

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares of restricted stock vest 100% on December 10, 2026.

2. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2023.

3. Includes shares of restricted stock which vest in three equal annual installments commencing on December 16, 2024.

4. Includes shares of restricted stock which vest in three equal annual installments commencing on December 9, 2025.

5. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026.

6. Includes shares of restricted stock which vest in three equal annual installments commencing on December 3, 2027.

7. Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027.

	/s/ Eric S. Bader, pursuant to power of attorney	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Esquire Financial Holdings (ESQ) report?

A director of Esquire Financial Holdings, Inc. received a grant of 753 shares of restricted common stock on December 10, 2025 at $0 per share.

When do the newly granted ESQ restricted shares vest?

The 753 restricted shares granted on December 10, 2025 are scheduled to vest 100% on December 10, 2026.

How many Esquire Financial (ESQ) shares does the director own after the transaction?

Following the grant, the director directly beneficially owns 142,679 shares of common stock and indirectly owns 2,500 shares through insurance trust I and 2,500 shares through insurance trust II.

What is the director’s relationship to Esquire Financial Holdings (ESQ)?

The reporting person is a director of Esquire Financial Holdings, Inc., as indicated in the filing.

What other restricted stock awards are included in the director’s ESQ holdings?

The director’s holdings include restricted stock that vests in three equal annual installments commencing on December 19, 2023, December 16, 2024, December 9, 2025, December 19, 2026, December 3, 2027, and December 15, 2027.

Is the Esquire Financial (ESQ) filing a joint or individual insider report?

The document indicates that it is a Form filed by one reporting person, not a joint filing.